Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia
Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines in the Russian Federation underwent substantial changes. As part of this work, legal aspects of clinical guidelines were modified. The present review, conducted on behalf of the Ministry of Health, is aimed...
Main Authors: | V. K. Fedyaeva, U. N. Dmitrieva, N. I. Juravleva, N. I. Juravlev, M. Yu. Kovaleva, A. S. Korobkina, O. A. Sukhorukikh, A. A. Pashkina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2019-10-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/305 |
Similar Items
-
The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation
by: N. I. Zhuravleva, et al.
Published: (2019-05-01) -
Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method
by: O. O. Buzuverova, et al.
Published: (2020-02-01) -
Evidence-based pharmacotherapy in cardiology. National guideline
by: S. Yu. Martsevich, et al.
Published: (2024-03-01) -
How frequently should “living” guidelines be updated? Insights from the Australian Living Stroke Guidelines
by: Tari Turner, et al.
Published: (2022-06-01) -
Is it possible to make ‘living’ guidelines? An evaluation of the Australian Living Stroke Guidelines
by: Louise Wiles, et al.
Published: (2024-04-01)